Live feed07:00:00·11hPRReleasevia QuantisnowBREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and olderByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
